JW Pharmaceutical Corp Capital Reinvestment Ratio
JW Pharmaceutical Corp capital reinvestment ratio. JW Pharmaceutical Corp (001067) has a Capital Reinvestment Ratio of 0.21x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩46.92 Billion) in capital expenditures (₩9.80 Billion). Check 001067 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of JW Pharmaceutical Corp (2014–2024)
Capital reinvestment ratio of JW Pharmaceutical Corp from 2014 to 2024. This chart tracks JW Pharmaceutical Corp's Capital Reinvestment Ratio across 10 annual periods. Also explore 001067 shareholders equity momentum to track the company's year-over-year net asset growth rate.
JW Pharmaceutical Corp Capital Reinvestment Ratio by Year (2014–2024)
JW Pharmaceutical Corp capital reinvestment ratio by year from 2014 to 2024. For the full cash flow conversion analysis, see JW Pharmaceutical Corp cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.35x | ₩79.39 Billion | ₩28.14 Billion | ▼ -24.1% |
| 2023 | 0.47x | ₩87.16 Billion | ₩40.71 Billion | ▲ +167.3% |
| 2022 | 0.17x | ₩56.76 Billion | ₩9.92 Billion | ▼ -57.6% |
| 2021 | 0.41x | ₩18.12 Billion | ₩7.47 Billion | ▲ +109.7% |
| 2020 | 0.20x | ₩63.05 Billion | ₩12.39 Billion | ▲ +17.5% |
| 2019 | 0.17x | ₩55.53 Billion | ₩9.28 Billion | ▲ +0.9% |
| 2018 | 0.17x | ₩52.11 Billion | ₩8.64 Billion | ▼ -26.1% |
| 2017 | 0.22x | ₩33.45 Billion | ₩7.50 Billion | ▼ -84.9% |
| 2016 | 1.49x | ₩6.74 Billion | ₩10.02 Billion | ▲ +56.2% |
| 2014 | 0.95x | ₩7.28 Billion | ₩6.93 Billion | — |